Ad is loading...
ALNY
Price
$248.79
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
76 days until earnings call
ARWR
Price
$18.71
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
4 days until earnings call
Ad is loading...

ALNY vs ARWR

Header iconALNY vs ARWR Comparison
Open Charts ALNY vs ARWRBanner chart's image
Alnylam Pharmaceuticals
Price$248.79
Change-$0.00 (-0.00%)
Volume$1.06M
CapitalizationN/A
Arrowhead Pharmaceuticals
Price$18.71
Change-$0.00 (-0.00%)
Volume$792.15K
CapitalizationN/A
ALNY vs ARWR Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALNY vs. ARWR commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongSell and ARWR is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ALNY: $246.80 vs. ARWR: $18.28)
Brand notoriety: ALNY: Not notable vs. ARWR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 82% vs. ARWR: 69%
Market capitalization -- ALNY: $32.09B vs. ARWR: $2.27B
ALNY [@Biotechnology] is valued at $32.09B. ARWR’s [@Biotechnology] market capitalization is $2.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileARWR’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ARWR’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ARWR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ARWR’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 6 bearish.
  • ARWR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ALNY and ARWR are a bad buy in the short-term.

Price Growth

ALNY (@Biotechnology) experienced а -4.31% price change this week, while ARWR (@Biotechnology) price change was -14.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 06, 2025.

ARWR is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($32.1B) has a higher market cap than ARWR($2.27B). ALNY YTD gains are higher at: 28.938 vs. ARWR (-40.261). ALNY has higher annual earnings (EBITDA): -85.69M vs. ARWR (-508.26M). ALNY has more cash in the bank: 2.78B vs. ARWR (434M). ARWR has less debt than ALNY: ARWR (118M) vs ALNY (1.3B). ALNY has higher revenues than ARWR: ALNY (2.1B) vs ARWR (19.6M).
ALNYARWRALNY / ARWR
Capitalization32.1B2.27B1,413%
EBITDA-85.69M-508.26M17%
Gain YTD28.938-40.261-72%
P/E RatioN/AN/A-
Revenue2.1B19.6M10,689%
Total Cash2.78B434M641%
Total Debt1.3B118M1,103%
FUNDAMENTALS RATINGS
ALNY vs ARWR: Fundamental Ratings
ALNY
ARWR
OUTLOOK RATING
1..100
5418
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
19100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4683
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
9595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARWR's Valuation (95) in the Biotechnology industry is in the same range as ALNY (99). This means that ARWR’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (19) in the Biotechnology industry is significantly better than the same rating for ARWR (100). This means that ALNY’s stock grew significantly faster than ARWR’s over the last 12 months.

ARWR's SMR Rating (98) in the Biotechnology industry is in the same range as ALNY (100). This means that ARWR’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for ARWR (83). This means that ALNY’s stock grew somewhat faster than ARWR’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ALNY (100). This means that ARWR’s stock grew significantly faster than ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYARWR
RSI
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Ad is loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STSOX44.590.78
+1.78%
Sterling Capital SmCp Val C
PGRSX9.830.03
+0.31%
Principal Global Real Estate Sec R6
STESX13.070.04
+0.31%
Bernstein International Strat Eqs SCB
GIRGX22.92N/A
N/A
Goldman Sachs U.S. Equity ESG Inv
BCSKX8.75N/A
N/A
BlackRock Commodity Strategies K

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.80%
IONS - ALNY
48%
Loosely correlated
-4.12%
ATRA - ALNY
44%
Loosely correlated
-0.66%
SGMO - ALNY
42%
Loosely correlated
+0.51%
AMLX - ALNY
40%
Loosely correlated
-0.76%
VXRT - ALNY
40%
Loosely correlated
-1.40%
More

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-2.30%
NTLA - ARWR
50%
Loosely correlated
+5.18%
CRNX - ARWR
48%
Loosely correlated
+1.71%
EDIT - ARWR
47%
Loosely correlated
-1.66%
BEAM - ARWR
46%
Loosely correlated
-3.72%
ALNY - ARWR
46%
Loosely correlated
-0.80%
More